| Type | Description |
|---|---|
| Definition | baculoviral IAP repeat containing 5 |
| Date | Results | Publications |
|---|---|---|
| 2017-11-11 12:54:00 | The results indicate that survivin is commonly expressed in canine lymphomas and that survivin does not exhibit anti-apoptotic activity in canine lymphomas. | 28865215 |
| 2017-04-15 10:56:00 | These findings strongly suggest that survivin-directed therapies might be effective in treatment of canine lymphoma and osteoporosis and support evaluation of EZN-3042 in dogs with cancer. | 24923332 |
| 2014-11-22 13:01:00 | These findings suggest that survivin could play an important role in the maintenance of the hair follicle cycle as well as in tumour initiation and maintenance of cancer stem cells. | 24800266 |
| 2013-02-16 11:34:00 | The level of survivin expression increased with increasing malignancy, designating survivin as a new diagnostic marker in the assessment of malignancy of sebaceous tumours. | 22681570 |
| 2011-12-27 05:36:00 | Malignant proliferation in canine hemangiosarcomas is associated with bcl-2 and survivin expression. | 18479697 |
| Type | IDs |
|---|---|
| Gene |
UniProtKB-ID:
BIRC5_CANLF,
A0A140DDC9_CANLF
UniprotKB:
Q8I009,
A0A140DDC9
UniParc:
UPI0000376312
EMBL:
AY741504,
AB180206,
KT693114
KO:
cfa:442936
|
| Nucleutide sequences |
EMBL-CDS:
AAU89275.1,
BAD20570.1,
AMK38056.1
|
| Protein sequencees |
RefSeq:
XP_851282.2,
NP_001003348.1,
XP_022278249.1
|
| Others |
UniRef100:
UniRef100_Q8I009
UniRef90:
UniRef90_Q8I009
UniRef50:
UniRef50_Q8I009
UniGene:
Cfa.33943
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员